Provided by Tiger Trade Technology Pte. Ltd.

Lantern Pharma Inc.

1.71
-0.0500-2.84%
Post-market: 1.710.00000.00%16:10 EDT
Volume:109.81K
Turnover:191.30K
Market Cap:21.82M
PE:-1.05
High:1.82
Open:1.78
Low:1.70
Close:1.76
52wk High:4.70
52wk Low:1.11
Shares:12.76M
Float Shares:10.14M
Volume Ratio:0.57
T/O Rate:1.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6362
EPS(LYR):-1.5709
ROE:-400.92%
ROA:-74.29%
PB:-6.78
PE(LYR):-1.09

Loading ...

Promising Penny Stocks To Consider In May 2026

Simply Wall St.
·
May 15

Lantern Pharma Directors Make Bold Insider Moves That Investors Can’t Ignore

TIPRANKS
·
May 15

Lantern Pharma raises capital, plans AI platform spinoff

TIPRANKS
·
May 15

Lantern Pharma director Lee T. Schalop acquires 48,544 shares for $99,999.64

Reuters
·
May 15

Lantern Pharma Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
May 14

Lantern Pharma prices 2.14M shares at $2.06 in registered direct offering

TIPRANKS
·
May 14

Lantern Pharma issues unregistered warrants in private placement for 2,135,923 shares

Reuters
·
May 13

Lantern Pharma prices registered direct offering at $2.06 per share, raises $4.4 million

Reuters
·
May 13

Lantern Pharma Inc. Announces up to $9.25 Million Registered Direct Offering With Existing Holders and a Single Institutional Investor

THOMSON REUTERS
·
May 13

Press Release: Lantern Pharma to Report First Quarter 2026 Operating & Financial Results on May 15th, 2026

Dow Jones
·
May 12

Lantern Pharma schedules first-quarter results update

Reuters
·
May 12

Lantern Pharma Inc expected to post a loss of 36 cents a share - Earnings Preview

Reuters
·
May 11

Lantern Pharma unveils roadmap for withZeta.ai

TIPRANKS
·
May 08

Lantern Pharma plans ZetaSwarm, ZetaOmics additions to withZeta.ai in coming year

Reuters
·
May 07

Lantern Pharma announces expansion of predictBBB.ai into LQM

TIPRANKS
·
Apr 29

Lantern Pharma expands predictBBB.ai into real-time small-molecule quantitative model web service

Reuters
·
Apr 29

Lantern Pharma to host live public demo of withZeta.ai platform in two sessions

Reuters
·
Apr 24

Lantern Pharma schedules Type C meeting with FDA for Phase 2 HARMONIC trial

TIPRANKS
·
Apr 20

BRIEF-Lantern Pharma Inc - Schedules Type C FDA Meeting For Harmonic Protocol Amendments

Reuters
·
Apr 20

Lantern Pharma Inc - Lp-300 Demonstrates 8.3-Month Median Progression-Free Survival With No Added Toxicity

THOMSON REUTERS
·
Apr 20